In vivo regulation of inducible no synthase in immune-mediated liver injury in mice.

Standard

In vivo regulation of inducible no synthase in immune-mediated liver injury in mice. / Koerber, Kerstin; Sass, Gabriele; Kiemer, Alexandra K; Vollmar, Angelika M; Tiegs, Gisa.

In: HEPATOLOGY, Vol. 36, No. 5, 5, 2002, p. 1061-1069.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Koerber, K, Sass, G, Kiemer, AK, Vollmar, AM & Tiegs, G 2002, 'In vivo regulation of inducible no synthase in immune-mediated liver injury in mice.', HEPATOLOGY, vol. 36, no. 5, 5, pp. 1061-1069. <http://www.ncbi.nlm.nih.gov/pubmed/12395315?dopt=Citation>

APA

Vancouver

Koerber K, Sass G, Kiemer AK, Vollmar AM, Tiegs G. In vivo regulation of inducible no synthase in immune-mediated liver injury in mice. HEPATOLOGY. 2002;36(5):1061-1069. 5.

Bibtex

@article{cb3acb13e82a4257b82bbe98679a550a,
title = "In vivo regulation of inducible no synthase in immune-mediated liver injury in mice.",
abstract = "Inducible nitric oxide synthase (iNOS) has been shown to play an important role in the development of liver injury. iNOS deficiency protects mice from hemorrhage/resuscitation as well as from cytokine-mediated liver injury, for example, after administration of concanavalin A (con A). Here we investigated the in vivo effects of tumor necrosis factor (TNF)-alpha and/or interferon (IFN)-gamma, two mediators of con A-induced liver injury, the TNF receptor (TNFR) usage leading to iNOS expression, and its connection with nuclear factor kappaB (NF-kappaB) activation. In conclusion, iNOS expression in vivo is dependent on both TNF-alpha and IFN-gamma. Although con A-induced liver injury depends on both TNFR1 and TNFR2, TNF-dependent iNOS expression is mediated exclusively by TNFR1 and requires NF-kappaB activation.",
keywords = "Animals, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, NF-kappa B/metabolism, Concanavalin A, Drug-Induced Liver Injury, Nitric Oxide Synthase Type II, Receptors, Tumor Necrosis Factor, Type II, Signal Transduction/immunology, Antibodies/pharmacology, Antigens, CD/immunology/metabolism, Gene Expression Regulation, Enzymologic/immunology, Interferon-gamma/immunology/metabolism, Liver Diseases/*enzymology/*immunology, Nitric Oxide Synthase/*genetics/*immunology/metabolism, Receptors, Tumor Necrosis Factor/immunology/metabolism, Receptors, Tumor Necrosis Factor, Type I, Tumor Necrosis Factor-alpha/immunology/metabolism, Animals, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, NF-kappa B/metabolism, Concanavalin A, Drug-Induced Liver Injury, Nitric Oxide Synthase Type II, Receptors, Tumor Necrosis Factor, Type II, Signal Transduction/immunology, Antibodies/pharmacology, Antigens, CD/immunology/metabolism, Gene Expression Regulation, Enzymologic/immunology, Interferon-gamma/immunology/metabolism, Liver Diseases/*enzymology/*immunology, Nitric Oxide Synthase/*genetics/*immunology/metabolism, Receptors, Tumor Necrosis Factor/immunology/metabolism, Receptors, Tumor Necrosis Factor, Type I, Tumor Necrosis Factor-alpha/immunology/metabolism",
author = "Kerstin Koerber and Gabriele Sass and Kiemer, {Alexandra K} and Vollmar, {Angelika M} and Gisa Tiegs",
year = "2002",
language = "English",
volume = "36",
pages = "1061--1069",
journal = "HEPATOLOGY",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - In vivo regulation of inducible no synthase in immune-mediated liver injury in mice.

AU - Koerber, Kerstin

AU - Sass, Gabriele

AU - Kiemer, Alexandra K

AU - Vollmar, Angelika M

AU - Tiegs, Gisa

PY - 2002

Y1 - 2002

N2 - Inducible nitric oxide synthase (iNOS) has been shown to play an important role in the development of liver injury. iNOS deficiency protects mice from hemorrhage/resuscitation as well as from cytokine-mediated liver injury, for example, after administration of concanavalin A (con A). Here we investigated the in vivo effects of tumor necrosis factor (TNF)-alpha and/or interferon (IFN)-gamma, two mediators of con A-induced liver injury, the TNF receptor (TNFR) usage leading to iNOS expression, and its connection with nuclear factor kappaB (NF-kappaB) activation. In conclusion, iNOS expression in vivo is dependent on both TNF-alpha and IFN-gamma. Although con A-induced liver injury depends on both TNFR1 and TNFR2, TNF-dependent iNOS expression is mediated exclusively by TNFR1 and requires NF-kappaB activation.

AB - Inducible nitric oxide synthase (iNOS) has been shown to play an important role in the development of liver injury. iNOS deficiency protects mice from hemorrhage/resuscitation as well as from cytokine-mediated liver injury, for example, after administration of concanavalin A (con A). Here we investigated the in vivo effects of tumor necrosis factor (TNF)-alpha and/or interferon (IFN)-gamma, two mediators of con A-induced liver injury, the TNF receptor (TNFR) usage leading to iNOS expression, and its connection with nuclear factor kappaB (NF-kappaB) activation. In conclusion, iNOS expression in vivo is dependent on both TNF-alpha and IFN-gamma. Although con A-induced liver injury depends on both TNFR1 and TNFR2, TNF-dependent iNOS expression is mediated exclusively by TNFR1 and requires NF-kappaB activation.

KW - Animals

KW - Mice

KW - Mice, Inbred BALB C

KW - Mice, Inbred C57BL

KW - Mice, Knockout

KW - NF-kappa B/metabolism

KW - Concanavalin A

KW - Drug-Induced Liver Injury

KW - Nitric Oxide Synthase Type II

KW - Receptors, Tumor Necrosis Factor, Type II

KW - Signal Transduction/immunology

KW - Antibodies/pharmacology

KW - Antigens, CD/immunology/metabolism

KW - Gene Expression Regulation, Enzymologic/immunology

KW - Interferon-gamma/immunology/metabolism

KW - Liver Diseases/enzymology/immunology

KW - Nitric Oxide Synthase/genetics/immunology/metabolism

KW - Receptors, Tumor Necrosis Factor/immunology/metabolism

KW - Receptors, Tumor Necrosis Factor, Type I

KW - Tumor Necrosis Factor-alpha/immunology/metabolism

KW - Animals

KW - Mice

KW - Mice, Inbred BALB C

KW - Mice, Inbred C57BL

KW - Mice, Knockout

KW - NF-kappa B/metabolism

KW - Concanavalin A

KW - Drug-Induced Liver Injury

KW - Nitric Oxide Synthase Type II

KW - Receptors, Tumor Necrosis Factor, Type II

KW - Signal Transduction/immunology

KW - Antibodies/pharmacology

KW - Antigens, CD/immunology/metabolism

KW - Gene Expression Regulation, Enzymologic/immunology

KW - Interferon-gamma/immunology/metabolism

KW - Liver Diseases/enzymology/immunology

KW - Nitric Oxide Synthase/genetics/immunology/metabolism

KW - Receptors, Tumor Necrosis Factor/immunology/metabolism

KW - Receptors, Tumor Necrosis Factor, Type I

KW - Tumor Necrosis Factor-alpha/immunology/metabolism

M3 - SCORING: Journal article

VL - 36

SP - 1061

EP - 1069

JO - HEPATOLOGY

JF - HEPATOLOGY

SN - 0270-9139

IS - 5

M1 - 5

ER -